news
Insilico and David Sinclair Open-Source Longevity AI for Personal Experiments
Insilico Medicine partnered with Harvard researcher David Sinclair to launch Longevity Grok, a free multi-agent AI system built to run personal N-of-1 health trials. The tool analyzes daily biomarker metrics to determine whether common interventions like magnesium or earlier bedtimes produce measurable biological shifts. It targets self-experimenters seeking hard data on their longevity protocols.
Insilico Medicine partnered with Harvard researcher David Sinclair to launch Longevity Grok, a free multi-agent AI system built to run personal N-of-1 health trials. The tool analyzes daily biomarker metrics to determine whether common interventions like magnesium or earlier bedtimes produce measurable biological shifts. It targets self-experimenters seeking hard data on their longevity protocols.
The architecture take
I spent three months taking apigenin before admitting I had no idea if my deep sleep actually improved or if I just liked the ritual. I used to think collecting more metrics solved that problem, but raw tracking without a follow-up protocol is just expensive static. Insilico and Sinclair are betting an open-source model running personal N-of-1 trials can force an honest answer. The tool ingests your sleep stages, resting heart rate, and fasting glucose, then calculates whether a 400 mg magnesium glycinate dose did anything measurable to your autonomic baseline. Boring data wins. I like the skepticism baked into this release (especially the admission that no current tool proves an extra year of life for healthy people). Most commercial longevity software sells certainty wrapped in a hefty monthly fee. Making the system free and auditable puts the focus back where it belongs: on whether your biology actually moved.